Advertisement

Reactions Weekly

, Volume 1679, Issue 1, pp 72–72 | Cite as

Epirubicin/trastuzumab

Decline in left ventricular ejection fraction, subclinical myocardial damage and cardiotoxicity: case report
Case report
  • 30 Downloads

Reference

  1. Kitayama H, et al. High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients. Breast Cancer 24: 774-782, No. 6, Nov 2017. Available from: URL: http://doi.org/10.1007/s12282-017-0778-8 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2017

Personalised recommendations